Review

Sources, diffusion and prediction in COVID-19 pandemic: lessons learned to face next health emergency

  • Scholars and experts argue that future pandemics and/or epidemics are inevitable events, and the problem is not whether they will occur, but when a new health emergency will emerge. In this uncertain scenario, one of the most important questions is an accurate prevention, preparedness and prediction for the next pandemic. The main goal of this study is twofold: first, the clarification of sources and factors that may trigger pandemic threats; second, the examination of prediction models of on-going pandemics, showing pros and cons. Results, based on in-depth systematic review, show the vital role of environmental factors in the spread of Coronavirus Disease 2019 (COVID-19), and many limitations of the epidemiologic models of prediction because of the complex interactions between the new viral agent SARS-CoV-2, environment and society that have generated variants and sub-variants with rapid transmission. The insights here are, whenever possible, to clarify these aspects associated with public health in order to provide lessons learned of health policy that may reduce risks of emergence and diffusion of new pandemics having negative societal impact.

    Citation: Mario Coccia. Sources, diffusion and prediction in COVID-19 pandemic: lessons learned to face next health emergency[J]. AIMS Public Health, 2023, 10(1): 145-168. doi: 10.3934/publichealth.2023012

    Related Papers:

    [1] Yuan Yang, Lingshan Zhou, Xi Gou, Guozhi Wu, Ya Zheng, Min Liu, Zhaofeng Chen, Yuping Wang, Rui Ji, Qinghong Guo, Yongning Zhou . Comprehensive analysis to identify DNA damage response-related lncRNA pairs as a prognostic and therapeutic biomarker in gastric cancer. Mathematical Biosciences and Engineering, 2022, 19(1): 595-611. doi: 10.3934/mbe.2022026
    [2] Yun-xiang Li, Shi-ming Wang, Chen-quan Li . Four-lncRNA immune prognostic signature for triple-negative breast cancer. Mathematical Biosciences and Engineering, 2021, 18(4): 3939-3956. doi: 10.3934/mbe.2021197
    [3] Zehao Niu, Yujian Xu, Yan Li, Youbai Chen, Yan Han . Construction and validation of a novel pyroptosis-related signature to predict prognosis in patients with cutaneous melanoma. Mathematical Biosciences and Engineering, 2022, 19(1): 688-706. doi: 10.3934/mbe.2022031
    [4] Chen Zheng, Zhaobang Tan . A novel identified pyroptosis-related prognostic signature of colorectal cancer. Mathematical Biosciences and Engineering, 2021, 18(6): 8783-8796. doi: 10.3934/mbe.2021433
    [5] Wei Niu, Lianping Jiang . A seven-gene prognostic model related to immune checkpoint PD-1 revealing overall survival in patients with lung adenocarcinoma. Mathematical Biosciences and Engineering, 2021, 18(5): 6136-6154. doi: 10.3934/mbe.2021307
    [6] Changxiang Huan, Jiaxin Gao . A novel cuproptosis-related lncRNA prognostic signature for predicting treatment and immune environment of head and neck squamous cell carcinoma. Mathematical Biosciences and Engineering, 2022, 19(12): 12127-12145. doi: 10.3934/mbe.2022564
    [7] Yong Ding, Jian-Hong Liu . The signature lncRNAs associated with the lung adenocarcinoma patients prognosis. Mathematical Biosciences and Engineering, 2020, 17(2): 1593-1603. doi: 10.3934/mbe.2020083
    [8] Yan He, Nannan Cao, Yanan Tian, Xuelin Wang, Qiaohong Xiao, Xiaojuan Tang, Jiaolong Huang, Tingting Zhu, Chunhui Hu, Ying Zhang, Jie Deng, Han Yu, Peng Duan . Development and validation of two redox-related genes associated with prognosis and immune microenvironment in endometrial carcinoma. Mathematical Biosciences and Engineering, 2023, 20(6): 10339-10357. doi: 10.3934/mbe.2023453
    [9] Jie Chen, Jinggui Chen, Bo Sun, Jianghong Wu, Chunyan Du . Integrative analysis of immune microenvironment-related CeRNA regulatory axis in gastric cancer. Mathematical Biosciences and Engineering, 2020, 17(4): 3953-3971. doi: 10.3934/mbe.2020219
    [10] Han Zhao, Yun Chen, Peijun Shen, Lan Gong . Construction and validation of a novel prognostic signature for uveal melanoma based on five metabolism-related genes. Mathematical Biosciences and Engineering, 2021, 18(6): 8045-8063. doi: 10.3934/mbe.2021399
  • Scholars and experts argue that future pandemics and/or epidemics are inevitable events, and the problem is not whether they will occur, but when a new health emergency will emerge. In this uncertain scenario, one of the most important questions is an accurate prevention, preparedness and prediction for the next pandemic. The main goal of this study is twofold: first, the clarification of sources and factors that may trigger pandemic threats; second, the examination of prediction models of on-going pandemics, showing pros and cons. Results, based on in-depth systematic review, show the vital role of environmental factors in the spread of Coronavirus Disease 2019 (COVID-19), and many limitations of the epidemiologic models of prediction because of the complex interactions between the new viral agent SARS-CoV-2, environment and society that have generated variants and sub-variants with rapid transmission. The insights here are, whenever possible, to clarify these aspects associated with public health in order to provide lessons learned of health policy that may reduce risks of emergence and diffusion of new pandemics having negative societal impact.



    Abbreviations: AJCC: American joint committee on cancer; AUC: Area under the curve; BP: Biological process; CC: Cellular component; COAD: Colon adenocarcinoma; CRC: Colorectal cancer; DEirlncRNA: Different expression immune related lncRNA; DEG: Different expression gene; GO: Gene ontology; HR: Hazard ratio; IRLP: Immune-related lncrna pair; KEGG: Kyoto encyclopedia of genes and genomes; LncRNA: Long non-coding RNA; MF: Molecular function; OS: Overall survival; PPI: Protein-protein interaction; READ: Rectum adenocarcinoma; ROC: Receiver operating characteristic; TCGA: The cancer genome atlas; TME: Tumor microenvironment

    According to the latest GLOBOCAN 2018 data, colorectal cancer (CRC) is the fourth most commonly diagnosed cancer worldwide (10.2%) and the fourth cause of malignancy related death in the world [1]. Due to a lack of notable symptoms in the early stages, most of patients usually diagnosed at an advanced stage with local progression or distant metastasis. Although there has been substantial progress in the management of CRC, the five years survival down to 50%-70.4% once metastasis occurs [2]. Therefore, there is an urgent need for the development of CRC early diagnosis.

    At present, the clinical TNM stage classification is most commonly used to detection of cancer stage and estimate prognosis in CRC patients. But, there still exist the problem that TNM stage system inconsistent with the five years survival in clinical [3,4]. Therefore, more effective and sensitive biomarkers are urgently needed for screening, diagnosis, prognosis in CRC. With the development of genetic testing, gene-based biomarkers have become more and more popular and improved the standard in the diagnosis and treatment of CRC [5].

    Long-non coding RNAs (lncRNAs) refer to a class of transcripts with over 200 nucleotides in length and have no or limited coding protein capacity [6]. LncRNAs are involved in diverse biological processes including cell cycle, cell differentiation and myogenesis [7]. Moreover, mounting evidence suggests that the tumor microenvironment (TME) serves pivotal roles in determining tumor behavior. Recently, tumor immunotherapy using the immune system to anti-tumor response and elimination of tumor cells are breakthrough treatments for several malignancies [8]. Therefore, the regulation of immune-related gene expression appears especially important in hosting immune responses to combat cancer cells. Although a majority of the studies thus far have focused on coding genes, researchers have begun to pay more attention to lncRNAs recently [9]. For example, lncRNA MIR17HG can directly bound to PD-L1 to regulate tumor-immune microenvironment and plays an oncogenic role in CRC [10]. And lncRNAs have also been verified as potential biomarkers for many cancers [11].

    In this study, we analyzed the data set of lncRNA expression in the cancer genome atlas (TCGA), and a prognostic model of 10 immune-related lncRNA pair (IRLP) associated with the clinical prognosis of CRC was identified according to bioinformatic prediction. The effect of the signature model involved in the regulation of tumor immune microenvironment and checkpoints. In addition, biological function and lncRNA-protein networks of the signature model were explored as well.

    The workflow of the analyses carried out in this study is shown in Figure 1 Co-expression module and differential expression analysis were used to identify immune-related lncRNAs from TCGA-COAD and -READ data. The patients were then divided randomly into the training and validating group. Thereafter, prognostic lncRNA pairs were determined using univariate Cox, Lasso, and multivariate Cox regression analysis. From these analyses, 10 IRLPs were used to construct a signature model. The model was then evaluated using ROC analysis, overall survival (OS), univariate and multivariate Cox, immune cell infiltration, immune checkpoints, GO enrichment and KEGG analysis, as well as lncRNA-protein interaction network. Lastly, the validating group was also tested against the signature model.

    Figure 1.  The technology roadmap.

    The COAD-FPKM and READ-FPKM RNA-seq data and their corresponding clinical data were retrieved from TCGA database (https://portal.gdc.cancer.gov). This dataset was composed of 488 CRC tissues and 42 paired non-cancerous normal tissues. In addition, a list of immune-related genes was downloaded from the ImmPort database (https://www.immport.org/). Data containing complete OS was used to determine the correlation between immune-related lncRNAs and the corresponding prognosis of CRC.

    We identified a list of immune-related genes from the ImmPort database and used the list to calculate the correlation between immune-related genes and lncRNAs from the TCGA database. LncRNAs with a correlation coefficient > 0.7 and p < 0.001 were selected for further analysis. Differential lncRNA expression between CRC and non-cancerous normal tissues was determined using the 'limma' package, and lncRNAs with |log2FC| > 1 and P value < 0.05 were considered as statistically significant. The patients were then divided randomly into the training (n = 325) and validation group (n = 163) in the ratio of 2:1. A pairwise comparison was performed between each lncRNA expression value within each sample of TCGA to obtain a score for IRLP signature. In each lncRNA pair, when the first gene exhibited a higher expression relative to the other one, the score was set to 1, otherwise was 0. Samples with a ratio of 0 and 1 less than 20% were excluded. We further carried out univariate (p < 0.01), LASSO and multivariate Cox regression analyses to select genes that were significantly associated with survival and included them in the IRLP signature. Receiver operating characteristic (ROC) curve analysis on the training dataset was used to determine the threshold risk score to divide the patients into high-risk and low-risk groups. The formula can be expressed as follows: RiskScore = ∑Ni = 1Expi*Wi, where exp is the expression value of every DEirlncRNA pair, and W is the multivariate cox regression analysis coefficient of each DEirlncRNA pair in the signature.

    The pairwise comparison analysis was performed in validation group (n = 163), and then the 'limma' package was used to screened out the identified 10 immune-related lncRNA pairs from the validating group. Furthermore, multivariate Cox regression analysis and the riskscore formula were performed to work out the risk score of each patient in validating group. And the ROC, OS, univariate and multivariate cox regression analysis were performed as well.

    ROC curve analysis was used to evaluate the performance of the IRLPs risk model (short for risk model) in predicting 1-, 2- and 3-years OS in the training cohort and validating cohort. Univariate and multivariate Cox proportional hazards regression analysis were employed to verify if the risk model was independent of age, gender, American Joint Committee on Cancer (AJCC) stage, T stage, N stage, and M stage as a prognostic factor. Afterwards, calibration curves and a nomogram representing the clinical parameters and the risk model were established to evaluate the risk model.

    CIBERSORT is an algorithm that employs linear support vector regression to characterize the cell composition of tissues based on their gene expression profiles [12]. We used CIBERSORT (https://cibersortx.stanford.edu/) to determine the degree of infiltration of the tumor microenvironment by 22 tumor-infiltrating immune cells. The results of this analysis were used to establish the relationship between the risk model and the number of tumor-infiltrating immune cells. We further characterized the tumor microenvironment through differential gene expression analysis of immune checkpoints between the high-and low-risk groups.

    Results of co-expression analysis identified 21 immune-related genes that correlated with 10 IRLPs. Gene ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enrichment analysis for the 21 immune-related genes was carried using DAVID Bioinformatics Resources (https://david.ncifcrf.gov/). Enrichment terms with count > 2 and p < 0.05 were selected for further analysis. The biological functional enrichments were visualized using the ggplot2 Package in R. Furthermore, we constructed and downloaded the protein–protein interaction (PPI) network of the 21 immune-related genes using the STRING database (https://string-db.org/) and along with the risk model were visualized using Cytoscape software (version 3.6.1). Ten hub genes in the network were chosen based on the MCC algorithm using cytoHubba app in Cytoscape.

    Statistical analysis was carried out using R software (version 3.6.3). The R packages used in this study include: 'Limma' (version 3.46.0), 'pheatmap' (1.0.12 version), 'Survival' (3.2-7 version), 'survminer' (0.4.8 version), 'glmnet' (version 4.0-2), 'survivalROC' (version 1.0.3), 'ggpubr' (0.4.0 version), 'ComplexHeatmap' (2.6.2 version) and 'ggplot2' (version 3.3.2). Pearson correlation was used to determine the linear association between two groups. P < 0.05 was considered to be significant. Statistical significance was defined as follows: *P < 0.05, **P < 0.01, ***P < 0.001.

    In this study, the TCGA CRC transcriptome data was used as an exploratory dataset (Figure 1). We used the immune-related gene list identified from ImmPort to select 1340 immune-related genes from the transcriptome data for further study. Co-expression analysis was used to select 302 immune-related lncRNAs with a Pearson correlation coefficient over 0.7. A total of 118 differentially expressed lncRNAs, including 102 up-regulated and 16 down-regulated lncRNAs, were identified from the normal and tumor tissues using edgeR. The heatmap and volcano plot of these differentially expressed lncRNAs are shown in Figures 2A, B.

    Figure 2.  Differential expression (DE) of LncRNAs between normal and CRC tumor tissues. (A) Heat maps of DE lncRNAs between normal and tumor tissues. (B) Vocano plots of DE lncRNAs between normal and tumor tissues.

    After the data was randomly divided into two groups, a pairwise comparison analysis was performed in the training group. A total of 4073 lncRNA pairs were obtained based on these differentially expressed lncRNAs. Univariate Cox regression analysis and Lasso Cox regression were used to select 13 IRLPs with prognostic potential in the training group (Figures 3A, B). Finally, multivariate Cox proportional hazards modeling was employed to select 10 IRLPs that were used to construct the risk model (Figures 3C, D). We also calculated the risk score for each patient in the TCGA dataset based on the risk model. ROC curve analysis was performed to determine the threshold value (2.199) of the model, that could categorize the patients into a high- or low-risk groups (Figure 3E).

    Figure 3.  The construction of the prognostic 10-gene immune-related lncRNA pair (IRLP) signature. (A, B) The establishment of the prognostic model based on LASSO penalized COX analysis. (C, D) The univariate and multivariate Cox analysis of the verified 10 lncRNAs signature model. (E) A ROC curve for the signature model and the threshold (2.199) used to assign patients to the high- or low-risk group.

    The Kaplan-Meier survival curves were used to compare the OS between the high- and low-risk groups in both the training (Figure 4A) and validating cohorts (Figure 4B). The OS of the low-risk group was significantly higher than that of the high-risk group in both cohorts. As shown in Figures 4C, D, the AUC values for the training cohort (0.842, 0.869 and 0.884 for the 1-, 2- and 3-year OS, respectively) and validating cohort (0.738, 0.690 and 0.739) showed that the risk model was able to discriminate between the high- and low-risk groups. In addition, the risk curves and scatterplots illustrated that the patients with higher risk scores had a higher risk of mortality in the training (Figures 4E, G) and validating cohorts (Figures 4G, H).

    Figure 4.  Clinical evaluation of the risk model. (A, B) Overall survival of CRC patients in the training and validating cohort using the risk model. (C, D) Time-dependent ROC analysis of predicting the overall survival of patients in the training and validating cohort using the risk model. (E-H) The distribution of the risk score and the survival status of CRC patients in the training and validating cohort using the risk model. The red points represent deaths, while the green points represent survivors.

    Univariate and multivariate Cox analyses were used to investigate if the 10-gene IRLPs risk model was independent of age, gender, AJCC stage, T stage, N stage, and M stage as a prognostic factor. The results showed that the risk model of univariate Cox analysis was 1.023 (Hazard Ratio (HR): 1.017-1.029, p < 0.001) and the multivariate Cox was 1.028 (HR: 1.019-1.037, p < 0.001) in the training cohort (Figures 5A, C), while the risk model of univariate and multivariate Cox analysis was 1.485 (HR: 1.210-1.822, p < 0.001) and 1.815 (HR: 1.380-2.387, p < 0.001) in the validating cohort, respectively (Figure 5B, D). On the other hand, the AUC values for the training cohort (0.842) and validating cohort (0.738) showed that the model had good discriminative ability when compared with clinical features (Figures E, F). As a result, the 10-gene IRLPs risk model can serve as an independent prognosis factor in CRC.

    Figure 5.  Assessment of the risk model and the prognostic value of clinical variables. (A, C) Univariate and multivariate Cox regression of the risk model and clinical parameters in training cohort of CRC. (B, D) Univariate and multivariate Cox regression of the risk model and clinical parameters in validating cohort of CRC. (E, F) ROC curves for the risk model and clinical parameters in training and validating cohorts of CRC.

    The correlation between the risk model and various clinical parameters was then assessed. The results showed that there were positive correlations between the risk score and age, clinical stage, T stage, N stage and M stage, while there was no relation between the risk score and patient gender (Figures 6A-F). A heatmap showing various clinical parameters differentially distributed in different cohorts is depicted in Figure 6G.

    Figure 6.  The correlation between the risk model and clinical parameters. (A-F) The correlation between the risk model and sex, age, AJCC stage, T, N, M stage. (G) Heat maps of clinical parameters between low-risk and high-risk groups.

    To further explore the ability of the risk model to predict the infiltration of immune cells in CRC, CIBERSORT was used to analyze the relationship between the risk score and 22 immune cells. Only Macrophages M0 infiltration was correlated with the risk model. High levels of Macrophages M0 were detected in the low-risk group (Figure 7A).

    Figure 7.  The correlation between the risk model and immune cell infiltration and immune checkpoints. (A) Relationship between the risk model and 22 kinds of tumor-infiltrating immune cells. (B) Relationship between the risk model and immune checkpoints.

    Immune checkpoints are molecules that modulate signaling pathways in the regulation of immune response and have an important role in the field of anti-cancer immunotherapy. According to the results shown in Figure 7, the expression levels of CD160, TNFSF15, HHLA2 and IDO2 were significantly higher in the low-risk group, while the levels of KIR3DL1 and PD-1 were higher in the high-risk group, although the latter had no significant difference (Figure 7B).

    The GO annotation system includes three major branches: cellular component (CC), biological process (BP) and molecular function (MF). GO and KEGG enrichment analysis were performed to predict the function of the 21 immune-related genes that correlated with the 10 IRLPs. The first three of these enrichments were as follows (Figure 8A-C): Neuronal cell body, plasma membrane and receptor complex were enriched for CC; while for BP, they were signal transduction by protein phosphorylation, activin receptor signaling pathway and signal transduction; and for MF, they include growth factor binding, receptor signaling protein serine/threonine kinase activity and transmembrane receptor protein serine/threonine kinase activity. Further analysis of KEGG pathways included 31 pathways, containing Chronic myeloid leukemia, ErbB signaling pathway and Pathways in cancer (Figure 8D).

    Figure 8.  Biological function analysis and lncRNA-protein networks of the risk model. (A-D) GO enrichment analysis (CC, BP and MF) and KEGG pathway analysis according to the risk model. (E) The lncRNA-protein networks based on the risk model. (F) 10 hub genes in the network were chosen based on the MCC algorithm.

    Using the 21 immune-related genes downloaded from the STRING database and the 10 IRLPs, we established a lncRNA-protein network, which consisted of 38 nodes and 102 edges (Figure 8E). Ten hub genes, which include three lncRNAs (AL157786.1, LINC01355, AF117829.1) and seven protein coding gene (PIK3CA, SOS1, CBLB, CBL, CREB1, ACVR2A and TGFBR1) were identified from the lncRNA-protein network using the MCC algorithm (Figure 8F).

    CRC is one of the leading causes of cancer-related mortality in the world. Advances in CRC research has allowed the characterization of CRC into different molecular subtypes presenting with distinct clinical features [13]. On the other hand, LncRNAs have been shown to modulate cancer progression by influencing the molecular characteristics of tumors [14,15]. LncRNAs regulate various immune-related genes [16,17,18], and have recently been associated with drug resistance and immune escape in human cancers [19]. It is therefore important to establish an immune-related lncRNA signature for CRC that can be used to develop novel strategies for CRC prevention and treatment.

    We built the signature model using a method based on the ranking and pairing comparison of relative gene expression. And we used data retrieved from TCGA to construct a 10-gene IRLPs signature for the prognosis of CRC. Using the model, we divided the patients into two groups with different immune microenvironment for evaluating clinical features, immune cell infiltration, immune check-point, GO enrichment, KEGG analysis and the interaction network between lncRNAs and immune-related protein coding genes.

    We performed LASSO, univariate and multivariate Cox regression to select immune-related lncRNA pairs for establishing the IRLPs signature model. The model was composed of 10 immune-related lncRNA pairs containing 17 unique immune-related lncRNAs, which were overexpressed in cancer tissues compared to normal tissues. Each of the IRLPs was an independent prognostic factor for CRC patients. The model was able to categorize the CRC patients into low-risk and high-risk groups in the training and the validating cohorts and acted as an independent prognostic factor for CRC. Furthermore, ROC analysis revealed that the AUCs of the model (0.842 and 0.738 in training and validating cohorts, respectively) were higher than those of other clinical features. Although, there have been a series of methods for immune related lncRNA signature establishment, but the prognostic power of each study was different (Table 1) [20,21,22,23]. Firstly, the AUC value of our model was higher than that of models proposed in other studies. Secondly, we used a method based on the ranking and pairing comparison of relative gene expression, and this approach for constructing the model eliminates the need for data scaling and normalization when using different platforms [24,25]. Thirdly, our model contains relatively fewer lncRNAs, while maintaining a high AUC value. Therefore, considering clinical application value, the 10-gene IRLP risk signature is a reliable prognostic model with potential clinical significance.

    Table 1.  The comparison of studies about immune related lncRNA signature for CRC.
    study database methods lncRNA signature AUC (3 years)
    Feng et al TCGA-COAD, READ DElncRNAs, Cox regression analysis 8-immune related lncRNA 0.751
    Meng et al TCGA-COAD, READ univariate analysis, Lasso and Cox regression 16-immune-related lncRNA pair (30 lncRNAs) 0.875
    Yan et al TCGA-COAD, GEO (colon cancer) CIBERSORT algorithm, Cox regression analysis four-immune related lncRNA 0.659
    Mei et al TCGA-COAD univariate and multivariate Cox regression 14-immune related lncRNA 0.776
    this study TCGA-COAD, READ DElncRNAs, ranking and pairing comparison, univariate Cox, Lasso and multivariate Cox regression 10-immune-related lncRNA pair (17 lncRNAs) 0.884

     | Show Table
    DownLoad: CSV

    The CIBERSORT algorithm has high specificity and sensitivity [12], and is able to evaluate the gene expression data of 22 different types of immune cells. A recent study showed that the infiltration of tumors by M0 macrophages was associated with favorable prognosis [26], a finding that is consistent with the results from our study. And macrophages are indispensable in immunotherapy of tumor. It can remove anti-PD1 antibodies from T cells to weaken their response, when the antibodies target the PD1-PDL1 axis [27]. Cancer immunotherapy is a novel anti-cancer approach that targets immune checkpoint receptors such as PD1/PDL1 [28]. Therefore, we compared the expression of immune checkpoints between the low- and high-risk groups. The analysis showed that there was higher expression of inhibitory immune checkpoints (PD1 (no statistical significance) and KIR3DL1), and low expression of stimulatory checkpoints (CD160, HHLA2, IDO2 and TNFSF15), in the high-risk patients. The upregulation of KIR3DL1 causes a reduction in CD4+ T cell count and is associated with rapid disease progression [29]. Reduced CD160 expression impairs the function of NK cells, causes immune escape of cancer and is associated with poor outcomes in patients with hepatocellular carcinoma [30]. HHLA2 can promote tumor differentiation and increase the levels of CD8+ infiltrating lymphocytes. Downregulation of HHLA2 contributes to the immunosuppressive microenvironment and progression of ovarian cancer [31]. IDO2 acts as a stimulatory immune checkpoint to enhance the efficacy of dendritic cell-based cancer immunotherapy [32]. Finally, TNFSF15 is a member of the tumor necrosis factor family, and can influence the proliferation, activation and differentiation of immune cells [33]. Down regulation of TNFSF15 is associated with poor prognosis in various cancers [34,35,36]. Thus, the risk model might be a promising reference function for cancer immunotherapy.

    KEGG enrichment analysis was carried out to predict the biological pathways involved in the regulation of CRC by the 10-gene IRLP signature. The results indicated that the gene signature was enriched in pathways such as Chronic myeloid leukemia, ErbB signaling pathway, Pathways in cancer, Insulin signaling pathway and Signaling pathways regulating pluripotency of stem cells. These pathways play key roles in the progression of CRC. For example, CARF increases the expression of MAPK8 and JUN by binding directly to their promoters, which in turn activates the ErbB signaling pathway that maintains the stemness of CRC [37]. PIK3CA and BRAF are members of the Insulin signaling pathway, and are the most common biomarkers for the genetic testing of CRC. Mutations in PIK3CA and/or BRAF in CRC are associated with poor outcome [38], and PIK3CA mutation is associated with poor prognosis among patients with curatively resected CRC [39].

    To better understand the correlation between lncRNA and immune-related genes, a lncRNA-protein network was established. From this network, 10 hub genes were identified including 7 protein coding genes: PIK3CA, SOS1, CBLB, CBL, CREB1, ACVR2A and TGFBR1. These genes have been associated with CRC [39,40,41,42,43,44,45]. For example, SOS1 is a key activator and feedback node of KRAS, which is the most frequently mutated driver of CRC [46]. Downregulation of SOS1 expression can lead to decreased survival of cancer cells harboring a KRAS mutation [47]. CBL have been reported to promote the progression of colon cancer by forming a complex with MUC1 and CIN85, and increased level of CBL in the early stage of colon cancer contributes to a poor prognosis [42]. ACVR2A acts a protective factor and a decrease in its expression is crucial for cancer progression and distant metastasis and may serve as a prognostic biomarker for the patients with colon cancer [44].

    Here remain several limitations. On the one hand, our study was limited by its retrospective nature. Further prospective clinical researches are needed to validate these results. On the other hand, we only performed enrichment analysis and made assumptions regarding the function of 17 immune related lncRNAs without additional research for further understanding of the underlying mechanism.

    In conclusion, we constructed a 10-gene prognostic IRLPs signature for CRC patients based on the immune-related genes in the TCGA database. The signature was associated with immune checkpoints that play key roles in immune regulation and immunotherapy of CRC Molecular functional and lncRNA-protein network analysis were used to understand the molecular mechanisms underlying the carcinogenic effect and progression. Further prospective clinical researches and additional vitro experiments are needed to be done in the future study for making the results more convincing.

    This study was supported by the Natural Guiding Plan foundation of Liaoning Province, grant number [2019-ZD-0584]; Natural Grant Program foundation of Liaoning Province, grant number [2020-ZLLH-44]; National Science Foundation of China, grant number [81902383]; Revitalizing Liaoning Talents Program, grant number [XLYC1907004]; Cultivation Program of National Science Foundation of Liaoning Cancer Hospital, grant number [2021-ZLLH-03].

    All authors declare no conflicts of interest in this paper.



    Conflict of interests



    I declare that I am the sole author of this manuscript, and I have no known competing financial interests or personal relationships that could influence the work reported in this paper. This study has no funders.

    [1] Chowdhury T, Chowdhury H, Bontempi E, et al. (2022) Are mega-events super spreaders of infectious diseases similar to COVID-19? A look into Tokyo 2020 Olympics and Paralympics to improve preparedness of next international events. Environ Sci Pollut R 30: 10099-10109. https://doi.org/10.1007/s11356-022-22660-2
    [2] Coccia M (2020) Factors determining the diffusion of COVID-19 and suggested strategy to prevent future accelerated viral infectivity similar to COVID. Sci Total Environ 729: 138474. https://doi.org/10.1016/j.scitotenv.2020.138474
    [3] Coccia M (2020) Two mechanisms for accelerated diffusion of COVID-19 outbreaks in regions with high intensity of population and polluting industrialization: the air pollution-to-human and human-to-human transmission dynamics. MedRxiv . https://medrxiv.org/cgi/content/short/2020.04.06.20055657v1
    [4] Coccia M (2020) Effects of Air Pollution on COVID-19 and Public Health, Research Article-Environmental Economics-Environmental Policy. ResearchSquare . https://doi.org/10.21203/rs.3.rs-41354/v1
    [5] Coccia M (2021) Recurring waves of Covid-19 pandemic with different effects in public health. J Econ Bib 8: 28-45. http://dx.doi.org/10.1453/jeb.v8i1.2184
    [6] Coccia M (2021) High health expenditures and low exposure of population to air pollution as critical factors that can reduce fatality rate in COVID-19 pandemic crisis: a global analysis. Environ Res 199: 111339. https://doi.org/10.1016/j.envres.2021.111339
    [7] Coccia M (2021) Effects of the spread of COVID-19 on public health of polluted cities: results of the first wave for explaining the dejà vu in the second wave of COVID-19 pandemic and epidemics of future vital agents. Environ Sci Pollut R 28: 19147-19154. https://doi.org/10.1007/s11356-020-11662-7
    [8] Coccia M (2022) COVID-19 pandemic over 2020 (with lockdowns) and 2021 (with vaccinations): similar effects for seasonality and environmental factors. Environ Res 208: 112711. https://doi.org/10.1016/j.envres.2022.112711
    [9] Bontempi E, Coccia M (2021) International trade as critical parameter of COVID-19 spread that outclasses demographic, economic, environmental, and pollution factors. Environ Res 201: 111514. https://doi.org/10.1016/j.envres.2021.111514
    [10] Bontempi E, Coccia M, Vergalli S, et al. (2021) Can commercial trade represent the main indicator of the COVID-19 diffusion due to human-to-human interactions? A comparative analysis between Italy, France, and Spain. Environ Res 201: 111529. https://doi.org/10.1016/j.envres.2021.111529
    [11] Akan AP, Coccia M (2022) Changes of Air Pollution between Countries Because of Lockdowns to Face COVID-19 Pandemic. Appl Sci 12: 12806. https://doi.org/10.3390/app122412806
    [12] Coccia M (2022) Meta-analysis to explain unknown causes of the origins of SARS-COV-2. Environ Res 111: 113062. https://doi.org/10.1016/j.envres.2022.113062
    [13] Johns Hopkins Center for System Science and EngineeringCoronavirus COVID-19 Global Cases (2022).
    [14] Núñez-Delgado A, Bontempi E, Coccia M, et al. (2021) SARS-CoV-2 and other pathogenic microorganisms in the environment. Environ Res 201: 111606. https://doi.org/10.1016/j.envres.2021.111606
    [15] El-Sadr Wafaa M, Ashwin Vasan, Ayman El-Mohande (2023) Facing the New Covid-19 Reality. N Engl J Med 388: 385-387.
    [16] Coccia M (2023) Effects of strict containment policies on COVID-19 pandemic crisis: lessons to cope with next pandemic impacts. Environ Sci Pollut R 30: 2020-2028. https://doi.org/10.1007/s11356-022-22024-w
    [17] Coccia M (2021) The relation between length of lockdown, numbers of infected people and deaths of COVID-19, and economic growth of countries: Lessons learned to cope with future pandemics similar to COVID-19. Sci Total Environ 775: 145801. https://doi.org/10.1016/j.scitotenv.2021.145801
    [18] Coccia M (2022) Improving preparedness for next pandemics: Max level of COVID-19 vaccinations without social impositions to design effective health policy and avoid flawed democracies. Environ Res 213: 113566. https://doi.rg/10.1016/j.envres.2022.113566
    [19] Coccia M (2022) COVID-19 Vaccination is not a Sufficient Public Policy to face Crisis Management of next Pandemic Threats. Publc Organ Rev . https://doi.org/10.1007/s11115-022-00661-6
    [20] Farazmand A (2001) Handbook of crisis and emergency management. CRC Press.
    [21] Farazmand A Crisis and Emergency Management, Theory and Practice (2014).
    [22] Coccia M (2022) Preparedness of countries to face covid-19 pandemic crisis: Strategic positioning and underlying structural factors to support strategies of prevention of pandemic threats. Environ Res 203: 1678. https://doi.org/10.1016/j.envres.2021.111678
    [23] Dai H, Cao W, Tong X, et al. (2022) Global prediction model for COVID-19 pandemic with the characteristics of the multiple peaks and local fluctuations. BMC Med Res Methodol 22: 137. https://doi.org/10.1186/s12874-022-01604-x
    [24] Krechetov M, Esmaieeli Sikaroudi AM, Efrat A, et al. (2022) Prediction and prevention of pandemics via graphical model inference and convex programming. Sci Rep 12: 7599. https://doi.org/10.1038/s41598-022-11705-8
    [25] Kuvvetli Y, Deveci M, Paksoy T, et al. (2021) A predictive analytics model for COVID-19 pandemic using artificial neural networks. Decis Anal J 1: 100007. https://doi.org/10.1016/j.dajour.2021.100007
    [26] Liu Z, Magal P, Webb G (2021) Predicting the number of reported and unreported cases for the COVID-19 epidemics in China, South Korea, Italy, France, Germany and United Kingdom. J Theor Biol 509: 110501. https://doi.org/10.1016/j.jtbi.2020.110501
    [27] Šušteršič T, Blagojević A, Cvetković D, et al. (2021) Epidemiological Predictive Modeling of COVID-19 Infection: Development, Testing, and Implementation on the Population of the Benelux Union. Front Public Health 9: 727274.
    [28] Coccia M (2021) Pandemic Prevention: Lessons from COVID-19. Encyclopedia 1: 433-444.
    [29] Khandia R, Singhal S, Alqahtani T, et al. (2022) Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic. Environ Res 209: 112816. https://doi.org/10.1016/j.envres.2022.112816
    [30] Groh M (2014) Strategic Management in Times of Crisis. Am J Econ Sociol Bus Adm 6: 49-57. https://doi.org/10.3844/ajebasp.2014.49.57
    [31] Alsobh A (2022) Prediction of COVID-19 Disease by ARIMA Model and Tuning Hyperparameter Through GridSearchCV. Emerging Technologies in Data Mining and Information Security: Proceedings of IEMIS 2: 543-551.
    [32] Keshavamurthy R, Dixon S, Pazdernik KT, et al. (2022) Predicting infectious disease for biopreparedness and response: A systematic review of machine learning and deep learning approaches. One Health 15: 100439.
    [33] Magazzino C, Mele M, Coccia M (2022) A machine learning algorithm to analyze the effects of vaccination on COVID-19 mortality. Epidemiol Infect 150: e168. https://doi.org/10.1017/S0950268822001418
    [34] Coccia M (2022) Optimal levels of vaccination to reduce COVID-19 infected individuals and deaths: A global analysis. Environ Res 204: 112314. https://doi.org/10.1016/j.envres.2021.112314
    [35] Rosenfeld R, Tibshirani RJ (2021) Epidemic tracking and forecasting: Lessons learned from a tumultuous year. PNAS 118: e2111456118. https://doi.org/10.1073/pnas.2111456118
    [36] Collins GS, Ma J, Dhiman P (2021) There are no shortcuts in the development and validation of a COVID-19 prediction model. Transbound Emerg Dis 68: 210-211.
    [37] PubMedSearch (2023). Available from: https://pubmed.ncbi.nlm.nih.gov/.
    [38] ScopusStrart exploring (2023). Available from: https://www.scopus.com/search/form.uri?display=basic#basic.
    [39] Web of ScienceDocuments (2023). Available from: https://www.webofscience.com/wos/woscc/basic-search.
    [40] Herby J, Jonung L, Hanke SH (2022) A literature review and meta-analysis of the effects of lockdowns on COVID-19 mortality. Stud Appl Econ .
    [41] Petticrew M, Roberts H (2005) Systematic reviews in the social sciences: A practical guide. Malden, MA: Blackwell Publishing.
    [42] Shakeel SM, Kumar NS, Madalli PP, et al. (2021) Covid-19 prediction models: A systematic literature review. Osong Public Health and Research Perspectives 12: 215-229.
    [43] Clarke J (2011) What is a systematic review?. Evid-Based Nu 14: 64.
    [44] Daszak P, Olival KJ, Li H (2020) A strategy to prevent future epidemics similar to the 2019-nCoV outbreak. Biosafety and Health 2: 6-8. http://dx.doi.org/10.1016/j.bsheal.2020.01.003
    [45] Anderson RM, May RM (1991) Infectious Diseases of Humans: Dynamics and Control. Oxford Univisity Press.
    [46] Dobson AP, Carper ER (1996) Infectious diseases and human population history. Bioscience 46: 115-126.
    [47] Wolfe N, Dunavan C, Diamond J (2007) Origins of major human infectious diseases. Nature 447: 279-283. https://doi.org/10.1038/nature05775
    [48] Ménard AD, Trant JF (2020) A review and critique of academic lab safety research. Nat Chem 12: 17-25. https://doi.org/10.1038/s41557-019-0375-x
    [49] Hellman MA, Savage EP, Keefe TJ (1986) Epidemiology of accidents in academic chemistry laboratories. J Chem Educ 63: A267.
    [50] Van Noorden R (2013) Safety survey reveals lab risks. Nature 493: 9-10.
    [51] Ayi HR, Hon CY (2018) Safety culture and safety compliance in academic laboratories: A Canadian perspective. J Chem. Health Saf 25: 6-12.
    [52] Simmons HE, Matos B, Simpson SA (2017) Analysis of injury data to improve safety and training. J Chem Health Saf 24: 21-28.
    [53] Kou Y, Peng X, Dingwell CE, et al. (2021) Learning experience reports improve. Acad Res Saf J Che Educ 98: 150-157.
    [54] Li Na, Hu LF, Jin AJ, et al. (2019) Biosafety laboratory risk assessment. J Bios Biosecur 1: 90-92. https://doi.org/10.1016/j.jobb.2019.01.011
    [55] Jia P, Yang SJ (2020) China needs a national intelligent syndromic surveillance system. Nature Med 26: 990. https://doi.org/10.1038/s41591-020-0921-5
    [56] Yuan D, Gao W, Liang S, et al. (2020) Biosafety threats of the rapidly established labs for SARS-CoV-2 tests in China. Environ Int 143: 105964. https://doi.org/10.1016/j.envint.2020.105964
    [57] Coccia M (2020) An index to quantify environmental risk of exposure to future epidemics of the COVID-19 and similar viral agents: Theory and Practice. Environ Res 191: 110155. https://doi.org/10.1016/j.envres.2020.110155
    [58] Coccia M (2020) How (Un)sustainable Environments are Related to the Diffusion of COVID-19: The Relation between Coronavirus Disease 2019, Air Pollution, Wind Resource and Energy. Sustainability 12: 9709.
    [59] Coccia M (2021) How do low wind speeds and high levels of air pollution support the spread of COVID-19?. Atmos Pollut Res 12: 437-445. https://doi.org/10.1016/j.apr.2020.10.002
    [60] Coccia M (2021) The effects of atmospheric stability with low wind speed and of air pollution on the accelerated transmission dynamics of COVID-19. International Journal of Environmental Studies 78: 1-2. https://doi.org/10.1080/00207233.2020.1802937
    [61] Coccia M, Bellitto M (2018) A critique of human progress: a new definition and inconsistencies in society. Quaderni IRCrES-CNR 4: 51-67. http://dx.doi.org/10.23760/2499-6661.2018.017
    [62] Jones AM, Harrison RM (2004) The effects of meteorological factors on atmospheric bio aerosol concentrations-a review. Sci Total Environ 326: 151e180.
    [63] Wei M, Liu H, Chen J, et al. (2020) Effects of aerosol pollution on PM2.5-associated bacteria in typical inland and coastal cities of northern China during the winter heating season. Environ pollut 262: 114188. https://doi.org/10.1016/j.envpol.2020.114188
    [64] Zhong J, Zhang X, Dong Y, et al. (2018) Feedback effects of boundary-layer meteorological factors on explosive growth of PM2.5 during winter heavy pollution episodes in Beijing from 2013 to 2016. Atmos Chem Phys 18: 247-258.
    [65] Rosario DKA, Mutz YS, Bernardes PC, et al. (2020) Relationship between COVID-19 and weather: Case study in a tropical country. Int J Hyg Envir Heal 229: 113587.
    [66] Benati I, Coccia M (2022) Effective Contact Tracing System Minimizes COVID-19 Related Infections and Deaths: Policy Lessons to Reduce the Impact of Future Pandemic Diseases. J Public Admin Gov 12: 19-33. https://doi.org/10.5296/jpag.v12i3.19834
    [67] Bradshaw WJ, Alley EC, Huggins JH, et al. (2021) Bidirectional contact tracing could dramatically improve COVID-19 control. Nat Commun 12: 232.
    [68] Yalaman A, Basbug G, Elgin C, et al. (2021) Cross-country evidence on the association between contact tracing and COVID-19 case fatality rates. Sci Rep-UK 11: 2145. https://doi.org/10.1038/s41598-020-78760-x
    [69] Coccia M, Benati I (2018) Rewards in public administration: A proposed classification. J Soc Adm Sci 5: 68-80. http://dx.doi.org/10.1453/jsas.v5i2.1648
    [70] Zhan C, Chen J (2021) An investigation of testing capacity for evaluating and modeling the spread of coronavirus disease. Inform Sciences 561: 211-229.
    [71] Coccia M (2012) Political economy of R&D to support the modern competitiveness of nations and determinants of economic optimization and inertia. Technovation 3: 370-379. https://doi.org/10.1016/j.technovation.2012.03.005
    [72] Coccia M (2014) Driving forces of technological change: The relation between population growth and technological innovation-Analysis of the optimal interaction across countries. Technol Forecast Soc 8: 52-65. https://doi.org/10.1016/j.techfore.2013.06.001
    [73] Coccia M (2018) Classification of innovation considering technological interaction. J Econ Bib 5: 76-93. http://dx.doi.org/10.1453/jeb.v5i2.1650
    [74] Coccia M (2018) General properties of the evolution of research fields: a scientometric study of human microbiome, evolutionary robotics and astrobiology. Scientometrics 117: 1265-1283. https://doi.org/10.1007/s11192-018-2902-8
    [75] Coccia M (2018) Types of government and innovative performance of countries. J Soc Adm Sci 5: 15-33. http://dx.doi.org/10.1453/jsas.v5i1.1573
    [76] Coccia M (2019) Comparative Institutional Changes. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springer Nature. https://doi.org/10.1007/978-3-319-31816-5_1277-1
    [77] Coccia M (2019) Intrinsic and extrinsic incentives to support motivation and performance of public organizations. J Econ Biblio 6: 20-29. http://dx.doi.org/10.1453/jeb.v6i1.1795.
    [78] Coccia M (2019) Metabolism of Public Organizations. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springer Nature. https://doi.org/10.1007/978-3-319-31816-5_3711-1
    [79] Coccia M (2020) Fishbone diagram for technological analysis and foresight. Int J Foresight and Innovation Policy 14: 225-247.
    [80] Coccia M (2020) The evolution of scientific disciplines in applied sciences: dynamics and empirical properties of experimental physics. Scientometrics 124: 451-487. https://doi.org/10.1007/s11192-020-03464-y
    [81] Coccia M (2021) Comparative Critical Decisions in Management. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springer. https://doi.org/10.1007/978-3-319-31816-5_3969-1
    [82] Coccia M (2022) Critical innovation strategies for achieving competitive strategic entrepreneurship in ever-increasing turbulent markets. Strategic Entrepreneurship-Perspectives on Dynamics, Theories, and Practices . Springer. https://doi.org/10.1007/978-3-030-86032-5_12
    [83] Coccia M (2022) Technological trajectories in quantum computing to design a quantum ecosystem for industrial change. Technology Analysis & Strategic Management . https://doi.org/10.1080/09537325.2022.2110056
    [84] Coccia M, Benati I (2017) What is the relation between public manager compensation and government effectiveness? An explorative analysis with public management implications. Quaderni Ircres-CNR 2: 1-36. http://dx.doi.org/10.23760/2499-6661.2017.001
    [85] Coccia M, Mosleh M, Roshani S (2022) Evolution of quantum computing: Theoretical and innovation management implications for emerging quantum industry. IEEE Transactions on Engineering Management . https://doi.org/10.1109/TEM.2022.3175633
    [86] Coccia M, Roshani S, Mosleh M (2021) Scientific Developments and New Technological Trajectories in Sensor Research. Sensors 21: 7803. https://doi.org/10.3390/s21237803
    [87] Coccia M (2019) Revolutions and Evolutions. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springe. https://doi.org/10.1007/978-3-319-31816-5_3708-1
    [88] Coccia M, Roshani S, Mosleh M (2022) Evolution of Sensor Research for Clarifying the Dynamics and Properties of Future Directions. Sensors 22: 9419. https://doi.org/10.3390/s22239419
    [89] Mosleh M, Roshani S, Coccia M (2022) Scientific laws of research funding to support citations and diffusion of knowledge in life science. Scientometrics 127: 1931-1951. https://doi.org/10.1007/s11192-022-04300-1
    [90] Núñez-Delgado Avelino, Zhien Zhang, Elza Bontempi, et al. (2023) Editorial on the Topic “New Research on Detection and Removal of Emerging Pollutants”. Materials 16: 725. https://doi.org/10.3390/ma16020725
    [91] Pagliaro M, Coccia M (2021) How self-determination of scholars outclasses shrinking public research lab budgets, supporting scientific production: a case study and R&D management implications. Heliyon 7: e05998. https://doi.org/10.1016/j.heliyon.2021.e05998
    [92] Pronti A, Coccia M (2021) Agroecological and conventional agricultural systems: comparative analysis of coffee farms in Brazil for sustainable development. Int J Sustainable Development 2: 223-248. https://doi.org/10.1504/IJSD.2020.115223
    [93] Roshani S, Bagheri R, Mosleh M, et al. (2021) What is the relationship between research funding and citation-based performance? A comparative analysis between critical disciplines. Scientometrics 126: 7859-7874. https://doi.org/10.1007/s11192-021-04077-9
    [94] Roshani S, Coccia M, Mosleh M (2022) Sensor Technology for Opening New Pathways in Diagnosis and Therapeutics of Breast, Lung, Colorectal and Prostate Cancer. HighTech Innov 3: 356-375. http://dx.doi.org/10.28991/HIJ-2022-03-03-010
    [95] Sagan A, Thomas S, McKee M, et al. (2020) COVID-19 and health systems resilience: lessons going forwards. Eurohealth 26.
    [96] Benati I, Coccia M (2022) Global analysis of timely COVID-19 vaccinations: Improving governance to reinforce response policies for pandemic crises. Int J Health Gov . https://doi.org/10.1108/IJHG-07-2021-0072
    [97] Ajelli M (2018) The RAPIDD Ebola forecasting challenge: Model description and synthetic data generation. Epidemics 22: 3-12.
    [98] Johansson MA, Apfeldorf KM, Dobson S, et al. (2019) An open challenge to advance probabilistic forecasting for dengue epidemics. Proc Natl Acad Sci USA 116: 24268-24274.
    [99] Reinhart A, Brooks L, Jahja M, et al. (2021) An open repository of real-time COVID-19 indicators. Proc Natl Acad Sci USA 118: e2111452118.
    [100] McDonald DJ (2021) Can auxiliary indicators improve COVID-19 forecasting and hotspot prediction?. Proc Natl Acad Sci USA 118: e2111453118.
    [101] KhudaBukhsh WR, Bastian CD, Wascher M, et al. (2023) Projecting COVID-19 cases and hospital burden in Ohio. J Theor Biol 561: 111404.
    [102] Hurford A, Martignoni MM, Loredo-Osti JC, et al. (2023) Pandemic modelling for regions implementing an elimination strategy. J Theor Biol 561: 111378.
    [103] Khairulbahri M (2023) The SEIR model incorporating asymptomatic cases, behavioral measures, and lockdowns: Lesson learned from the COVID-19 flow in Sweden. Biomed Signal Proces 81: 104416.
    [104] Sasanami M, Fujimoto M, Kayano T, et al. (2023) Projecting the COVID-19 immune landscape in Japan in the presence of waning immunity and booster vaccination. J Theor Biol 559: 111384.
    [105] Li Z, Zhao J, Zhou Y, et al. (2023) Adaptive behaviors and vaccination on curbing COVID-19 transmission: Modeling simulations in eight countries. J Theor Biol 559: 111379.
    [106] Vasconcelos GL, Pessoa NL, Silva NB, et al. (2022) Multiple waves of COVID-19: a pathway model approach. Nonlinear Dyn . https://doi.org/10.1007/s11071-022-08179-8
    [107] Cherednik I (2022) Modeling the Waves of Covid-19. Acta Biotheor 70: 8. https://doi.org/10.1007/s10441-021-09428-w
    [108] Leonov A, Nagornov O, Tyuflin S (2023) Modeling of Mechanisms of Wave Formation for COVID-19. Epidemic Math 11: 167. https://doi.org/10.3390/math11010167
    [109] Cao Z, Qiu Z, Tang F, et al. (2022) Drivers and forecasts of multiple waves of the coronavirus disease 2019 pandemic: A systematic analysis based on an interpretable machine learning framework. Transbound Emerg Dis 69: e1584-e1594. https://doi.org/10.1111/tbed.14492
    [110] Namiki M, Yano R (2022) A numerical method to calculate multiple epidemic waves in COVID-19 with a realistic total number of people involved. J Stat Mech 2022: 033403.
    [111] Safaie Nasser, Kaveie Maryam, Mardanian Siroos, et al. (2022) Investigation of Factors Affecting COVID-19 and Sixth Wave Management Using a System Dynamics Approach. J Healthc Eng . https://doi.org/10.1155/2022/4079685
    [112] Wieland T (2020) A phenomenological approach to assessing the effectiveness of COVID-19 related nonpharmaceutical interventions in Germany. Safety Sci 131: 104924.
    [113] Douglas WA (2022) Covid-19 Lockdown Cost/Benefits: A Critical Assessment of the Literature. Int J Econ Bus 29: 1-32.
    [114] Biggs AT, Littlejohn LF (2021) Revisiting the initial COVID-19 pandemic projections. The Lancet Microbe 2: E91-E92.
    [115] Korolev I (2021) Identification and estimation of the SEIRD epidemic model for COVID-19. J Econometrics 220: 63-85.
    [116] Chen C, So M, Liu FC (2022) Assessing government policies' impact on the COVID-19 pandemic and elderly deaths in East Asia. Epidemiol Infect 150: e161. https://doi.org/10.1017/S0950268822001388
    [117] Mohammadi Z, Cojocaru MG, Thommes EW (2022) Human behaviour, NPI and mobility reduction effects on COVID-19 transmission in different countries of the world. BMC Public Health 22: 1594.
    [118] Stangier U, Kananian S, Schüller J (2022) Perceived vulnerability to disease, knowledge about COVID-19, and changes in preventive behavior during lockdown in a German convenience sample. Curr Psychol 41: 7362-7370.
    [119] Goolsbee A, Syverson C (2021) Fear, lockdown, and diversion: Comparing drivers of pandemic economic decline 2020. J Public Econ 193: 104311.
    [120] Amaro JE (2023) Systematic description of COVID-19 pandemic using exact SIR solutions and Gumbel distributions. Nonlinear Dyn 111: 1947-1969. https://doi.org/10.1007
    [121] Noteboom CB, Zeng D, Godasu R, et al. Applications of deep learning augmented systems for Covid-19 predictions- A literature review (2021).
    [122] Jordan E, Shin DE, Leekha S, et al. (2021) Optimization in the Context of COVID-19 Prediction and Control: A Literature Review. IEEE Access 9: 130072-130093. https://doi.org/10.1109/ACCESS.2021.3113812
    [123] Hudda MT, Archer L, van Smeden M, et al. (2023) Minimal reporting improvement after peer review in reports of COVID-19 prediction models: systematic review. J Clin Epidemiol 154: 75-84. https://doi.org/10.1016/j.jclinepi.2022.12.005
    [124] Zhang W, Liu S, Osgood N, et al. (2023) Using simulation modelling and systems science to help contain COVID-19: A systematic review. Syst Res Behav Sci 40: 207-234. https://doi.org/10.1002/sres.2897
    [125] Bhatia D, Allin S, Di Ruggiero E (2023) Mobilization of science advice by the Canadian federal government to support the COVID-19 pandemic response. Hum Soc Sci Commun 10: 19. https://doi.org/10.1057/s41599-023-01501-8
    [126] Bundy J, Pfarrer MD, Short CE, et al. (2017) Crises and Crisis Management: Integration, Interpretation, and Research Development. J Manage 43: 1661-1692. https://doi.org/10.1177/0149206316680030
    [127] Seeger MW, Sellno TL, Ulmer RR (1998) Communication, organization and crisis. Communication Yearbook 21: 231-275. https://doi.org/10.1080/23808985.1998.11678952
    [128] Mahmoudi J, Xiong C (2022) How social distancing, mobility, and preventive policies affect COVID-19 outcomes: Big data-driven evidence from the District of Columbia-Maryland-Virginia (DMV) megaregion. PloS One 17: e0263820. https://doi.org/10.1371/journal.pone.0263820
    [129] Cao S, Gan Y, Wang C, et al. (2020) Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China. Nat Commun 11: 5917. https://doi.org/10.1038/s41467-020-19802-w
    [130] Tsiotas D, Magafas L (2020) The Effect of Anti-COVID-19 Policies on the Evolution of the Disease: A Complex Network Analysis of the Successful Case of Greece. Physics 2: 325-339. https://doi.org/10.3390/physics2020017
    [131] Warren GW, Lofstedt R, Wardman JK (2021) COVID-19: the winter lockdown strategy in five European nations. J Risk Res 24: 267-293. https://doi.org/10.1080/13669877.2021.1891802
    [132] Crow DA, Albright EA, Ely T, et al. (2018) Do disasters lead to learning? Financial policy change in local government. Rev Policy Res 35: 564-589. https://doi.org/10.1111/ropr.12297
    [133] Kapitsinis N (2020) The underlying factors of the COVID-19 spatially uneven spread. Initial evidence from regions in nine EU countries. Reg Sci Policy Pract 12: 1027-1045. https://doi.org/10.1111/rsp3.12340
    [134] Williams GA, Ulla Díez SM, Figueras J, et al. (2020) Translating evidence into policy during the covid-19 pandemic: bridging science and policy (and politics). Eurohealth 26: 29-33.
    [135] Newby JM, O'Moore K, Tang S, et al. (2020) Acute mental health responses during the COVID-19 pandemic in Australia. PloS One 15: e0236562. https://doi.org/10.1371/journal.pone.0236562
    [136] Sirois FM, Owens J (2021) Factors Associated With Psychological Distress in Health-Care Workers During an Infectious Disease Outbreak: A Rapid Systematic Review of the Evidence. Front Psychiatry 11: 589545. https://doi.org/10.3389/fpsyt.2020.589545
    [137] Whittaker C, Kamaura LT, Takecian PL, et al. (2021) Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic. Science 371: 288-292. https://doi.org/10.1126/science.abe9728
    [138] Christie A, Brooks JT, Hicks LA, et al. (2021) Guidance for implementing COVID-19 prevention strategies in the context of varying community transmission levels and vaccination coverage. MMWR Morb Mortal Wkly Rep 70: 1044-1047.
    [139] Bleser WK, Shen H, Crook HL, et al. Health policy brief: pandemic-driven health policies to address social needs and health equity (2022). Available from: https://www.healthaffairs.org/do/10.1377/hpb20220210.360906/. opens in new tab.
    [140] Overton D, Ramkeesoon SA, Kirkpatrick K, et al. (2021) Lessons from the COVID-19 crisis on executing communications and engagement at the community level during a health crisis. Washington, DC: National Academies of Sciences, Engineering, and Medicine.
    [141] Ackoff RL, Rovin S (2003) Redesigning Society. Stanford: Stanford University Press.
    [142] Gigerenzer G, Todd PM (1999) Ecological rationality: the normative study of heuristics, Ecological Rationality: Intelligence in the World. New York: Oxford University Press 487-497.
    [143] Janssen M, van der Voort H (2020) Agile and adaptive governance in crisis response: Lessons from the COVID-19 pandemic. Int J Inform Manage 55: 102180.
    [144] Kahneman D, Slovic P, Tversky A (1982) Judgment Under Uncertainty: Heuristics and Biases. Cambridge University Press.
    [145] Weible CM, Nohrstedt D, Cairney P, et al. (2020) COVID-19 and the policy sciences: initial reactions and perspectives. Policy Sci 53: 225-241.
    [146] Liu XX, Fong SJ, Dey N, et al. (2021) A new SEAIRD pandemic prediction model with clinical and epidemiological data analysis on COVID-19 outbreak. Appl Intell 51: 4162-4198. https://doi.org/10.1007/s10489-020-01938-3
    [147] Chen B, Zhao Y, Jin Z, et al. (2023) Twice evasions of Omicron variants explain the temporal patterns in six Asian and Oceanic countries. Bmc Infect Dis 23: 25. https://doi.org/10.1186/s12879-023-07984-9
    [148] Milanesi S, Rosset F, Colaneri M, et al. (2023) Early detection of variants of concern via funnel plots of regional reproduction numbers. Scientific reports 13: 1052. https://doi.org/10.1038/s41598-022-27116-8
    [149] Cameron EE, Nuzz JR, Bell JA (2019) GHS Index Building. Global Health Security Index. Collective Action and Accountability . Washington, USA: Johns' Hopkins University.
    [150] Stribling J, Clifton A, McGill G, et al. (2020) Examining the UK Covid-19 mortality paradox: pandemic preparedness, healthcare expenditure, and the nursing workforce. J Adv Nurs 76: 3218-3227. https://doi.org/10.1111/jan.14562
    [151] Coccia M (2019) Comparative World-Systems Theories. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springer. https://doi.org/10.1007/978-3-319-31816-5_3705-1
    [152] Coccia M (2018) World-System Theory: A sociopolitical approach to explain World economic development in a capitalistic economy. J Econ Pol Econ 5: 459-465. http://dx.doi.org/10.1453/jepe.v5i4.1787
    [153] Coccia M (2017) The source and nature of general purpose technologies for supporting next K-waves: Global leadership and the case study of the U.S. Navy's Mobile User Objective System. Technol Forecast Soc 11: 331-339. https://doi.org/10.1016/j.techfore.2016.05.019
    [154] Coccia M (2015) General sources of general purpose technologies in complex societies: Theory of global leadership-driven innovation, warfare and human development. Technol Soc 42: 199-226. http://doi.org/10.1016/j.techsoc.2015.05.008
    [155] Coccia M (2019) The Role of Superpowers in Conflict Development and Resolutions. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springer. https://doi.org/10.1007/978-3-319-31816-5_3709-1
    [156] Coccia M (2020) Destructive Technologies for Industrial and Corporate Change. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springer. https://doi.org/10.1007/978-3-319-31816-5_3972-1
    [157] Coccia M (2019) Theories of Development. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springer. https://doi.org/10.1007/978-3-319-31816-5_939-1
    [158] Coccia M (2014) Converging scientific fields and new technological paradigms as main drivers of the division of scientific labour in drug discovery process: the effects on strategic management of the R&D corporate change. Technol Anal Strateg 26: 733-749. https://doi.org/10.1080/09537325.2014.882501
    [159] Coccia M (2016) Radical innovations as drivers of breakthroughs: characteristics and properties of the management of technology leading to superior organizational performance in the discovery process of R&D labs. Technol Anal Strateg 28: 381-395. https://doi.org/10.1080/09537325.2015.1095287
    [160] Coccia M (2020) Asymmetry of the technological cycle of disruptive innovations. Technol Anal Strateg 32: 1462-1477. https://doi.org/10.1080/09537325.2020.1785415
    [161] Coccia M (2021) Evolution and structure of research fields driven by crises and environmental threats: the COVID-19 research. Scientometrics 12: 9405-9429. https://doi.org/10.1007/s11192-021-04172-x
    [162] Coccia M (2019) Metabolism of public research organizations: how do laboratories consume state subsidies?. Publc Organ Rev 19: 473-491. https://doi.org/10.1007/s11115-018-0421-y
    [163] Coccia M (2021) Effects of human progress driven by technological change on physical and mental health. Studi Di Sociologia 2: 113-132. https://doi.org/10.26350/000309_000116
    [164] Coccia M (2018) Motivation and theory of self-determination: Some management implications in organizations. J Econ Bib 5: 223-230. http://dx.doi.org/10.1453/jeb.v5i4.1792
    [165] Coccia M (2017) New directions in measurement of economic growth, development and under development. J Econ Pol Econ 4: 382-395. http://dx.doi.org/10.1453/jepe.v4i4.1533
    [166] Coccia M (2010) Foresight of technological determinants and primary energy resources of future economic long waves. Int J Foresight Innov Policy 6: 225-232. https://doi.org/10.1504/IJFIP.2010.037468
    [167] Coccia M (2009) A new approach for measuring and analyzing patterns of regional economic growth: empirical analysis in Italy. A New Approach for Measuring and Analysing Patterns of Regional Economic Growth . https://doi.org/10.3280/SCRE2009-002004
    [168] Coccia M, Benati I (2018) Comparative Evaluation Systems. Global Encyclopedia of Public Administration, Public Policy, and Governance . Springer. https://doi.org/10.1007/978-3-319-31816-5_1210-1
    [169] Coccia M (2021) How a Good Governance of Institutions Can Reduce Poverty and Inequality in Society?. Legal-Economic Institutions, Entrepreneurship, and Management: Perspectives on the Dynamics of Institutional Change from Emerging Markets . Springer. https://doi.org/10.1007/978-3-030-60978-8_4
    [170] Coccia M (2018) Competition between basic and applied research in the organizational behaviour of public research labs. J Econ Lib 5: 118-133. http://dx.doi.org/10.1453/jel.v5i2.1652
    [171] Coccia M (2018) Economic inequality can generate unhappiness that leads to violent crime in society. Int J Happiness and Development 4: 1-24. https://doi.org/10.1504/IJHD.2018.090488
    [172] Coccia M (2022) Probability of discoveries between research fields to explain scientific and technological change. Technol Soc 68: 101874. https://doi.org/10.1016/j.techsoc.2022.101874
    [173] Coccia M (2021) Technological Innovation. The Blackwell Encyclopedia of Sociology . John Wiley & Son. https://doi.org/10.1002/9781405165518.wbeost011.pub2
    [174] Coccia M, Benati I (2018) Comparative Studies. Global Encyclopedia of Public Administration, Public Policy, and Governanc . Springer. https://doi.org/10.1007/978-3-319-31816-5_1197-1
  • This article has been cited by:

    1. Ivan Izonin, Nataliya Shakhovska, Special issue: informatics & data-driven medicine-2021, 2022, 19, 1551-0018, 9769, 10.3934/mbe.2022454
    2. Xiaojie Liang, Zhaoxiang Cheng, Xinhao Chen, Jun Li, Prognosis analysis of necroptosis-related genes in colorectal cancer based on bioinformatic analysis, 2022, 13, 1664-8021, 10.3389/fgene.2022.955424
    3. Jia He, Wenhan Wu, A glimpse of research cores and frontiers on the relationship between long noncoding RNAs (lncRNAs) and colorectal cancer (CRC) using the VOSviewer tool, 2023, 58, 0036-5521, 254, 10.1080/00365521.2022.2124537
    4. Abdullah Al-Danakh, Mohammed Safi, Yuli Jian, Linlin Yang, Xinqing Zhu, Qiwei Chen, Kangkang Yang, Shujing Wang, Jianjun Zhang, Deyong Yang, Aging-related biomarker discovery in the era of immune checkpoint inhibitors for cancer patients, 2024, 15, 1664-3224, 10.3389/fimmu.2024.1348189
    5. Agnieszka Kula, Dominika Koszewska, Anna Kot, Miriam Dawidowicz, Sylwia Mielcarska, Dariusz Waniczek, Elżbieta Świętochowska, The Importance of HHLA2 in Solid Tumors—A Review of the Literature, 2024, 13, 2073-4409, 794, 10.3390/cells13100794
    6. Yuekai Cui, Jie Mei, Shengsheng Zhao, Bingzi Zhu, Jianhua Lu, Hongzheng Li, Binglong Bai, Weijian Sun, Wenyu Jin, Xueqiong Zhu, Shangrui Rao, Yongdong Yi, Identification of a PANoptosis-related long noncoding rna risk signature for prognosis and immunology in colon adenocarcinoma, 2025, 25, 1471-2407, 10.1186/s12885-025-14021-2
  • Reader Comments
  • © 2023 the Author(s), licensee AIMS Press. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0)
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索

Metrics

Article views(4617) PDF downloads(203) Cited by(75)

Figures and Tables

Figures(4)  /  Tables(4)

Other Articles By Authors

/

DownLoad:  Full-Size Img  PowerPoint
Return
Return

Catalog